CGC2024@icgcs P.475

ICGCS Telegram 475

🔹Key Speaker of CGC2024
🔸Dr. Somaye Dehghanizadeh
Dr. Somaye Dehghanizadeh is the Scientific Manager at ReNAP Therapeutics Co., where she leads efforts in developing advanced cancer treatment strategies with a focus on the molecular mechanisms of cancer. She began her academic journey in Medicine at Tehran University of Medical Sciences, before transitioning to the Direct PhD Program in Biotechnology at University of Tehran. After earning her M.S. in Medical Biotechnology, Dr. Dehghanizadeh pursued a PhD in Molecular Biology and Oncological Sciences at University of Utah.During her PhD research, she focused on the genetic, epigenetic, and molecular biology of colon cancer at Huntsman Cancer Institute, making significant contributions to the understanding of cancer biology. At ReNAP Therapeutics Co., Dr. Dehghanizadeh continues her work on innovative cancer therapies, applying cutting-edge molecular approaches to improve patient outcomes.

🌐 WWW.ICGCS.COM
🔺 T.me/icgcs
🔺 instagram.com/icgcs

www.tgoop.com/icgcs/475

3.5K viewsedited Sep 30, 2024 at 17:44

tgoop.com/icgcs/475

Create: 2024-09-30
Last Update: 2025-02-24 08:55:11

🔹Key Speaker of CGC2024
🔸Dr. Somaye Dehghanizadeh
Dr. Somaye Dehghanizadeh is the Scientific Manager at ReNAP Therapeutics Co., where she leads efforts in developing advanced cancer treatment strategies with a focus on the molecular mechanisms of cancer. She began her academic journey in Medicine at Tehran University of Medical Sciences, before transitioning to the Direct PhD Program in Biotechnology at University of Tehran. After earning her M.S. in Medical Biotechnology, Dr. Dehghanizadeh pursued a PhD in Molecular Biology and Oncological Sciences at University of Utah.During her PhD research, she focused on the genetic, epigenetic, and molecular biology of colon cancer at Huntsman Cancer Institute, making significant contributions to the understanding of cancer biology. At ReNAP Therapeutics Co., Dr. Dehghanizadeh continues her work on innovative cancer therapies, applying cutting-edge molecular approaches to improve patient outcomes.

🌐 WWW.ICGCS.COM
🔺 T.me/icgcs
🔺 instagram.com/icgcs

BY CGC2024

Share with your friend now:
tgoop.com/icgcs/475

Open in Telegram

Telegram News

Date: 2025-02-24|

Telegram channels enable users to broadcast messages to multiple users simultaneously. Like on social media, users need to subscribe to your channel to get access to your content published by one or more administrators. How to build a private or public channel on Telegram? Image: Telegram. During a meeting with the president of the Supreme Electoral Court (TSE) on June 6, Telegram's Vice President Ilya Perekopsky announced the initiatives. According to the executive, Brazil is the first country in the world where Telegram is introducing the features, which could be expanded to other countries facing threats to democracy through the dissemination of false content. Write your hashtags in the language of your target audience.
from us

Telegram CGC2024
FROM American